Sisting of 62.2 fat, 19.6 carbohydrate, and 18.2 protein content on a caloric basis (Oriental Yeast, Tokyo, Japan). To assess the Teriparatide site effect of the HFD on glucose homeostasis, the body fat composition and fasting blood glucose (FBG) levels of the mice were examined by means of a LaTheta computed tomography (CT) system (Hitachi Aloka Medical, Tokyo, Japan) and a Drichem 3500 (Fujifilm, Tokyo, Japan), respectively. Bioluminescence images were collected every 4 weeks beginning when the mice were 6 weeks of age.Preparation of recombinant adenovirus vectorsRecombinant adenoviruses expressing mouse Pdx1, NeuroD (kindly gifted by Dr S. Yoshida), and MafA were prepared 12926553 using a ViraPower Adenoviral Gateway Expression Kit (Invitrogen) [26]. In brief, cDNA fragments were cloned into a pENTR4 entryIns1-luc BAC Transgenic Micefrom the pancreas (Figure 2E). To examine the effect of overnight fasting on BLI, the BLI signals under the fasting and fed states of the same set of male Ins1-luc BAC transgenic mice (n = 5) were imaged at 3-day intervals. The intensity of the BLI signal under the fasting state (2.060.776106 photons/sec) did not differ from that under the fed state (1.7360.826106 photons/sec; P = 0.814) (Figure 2F). Furthermore, the intensity of the BLI signal emitted in females (2.5961.36106 photons/sec; n = 15) did not differ from that emitted in males (5.4161.36106 photons/sec; n = 19) at 8 weeks of age (P = 0.13). Although signal attenuation in RIP-Luc mice over generations was reported because of a genomic imprinting of the transgene [27], we did not find the phenomenon in Ins1-luc BAC transgenic mice over 3 generations (data not shown). Next, we compared the glucose homeostasis of control WT mice with that of Ins1-luc BAC transgenic mice. Every examination we tested, including blood glucose levels and insulin content in pancreatic islets, showed no difference between them, indicating that Ins1-luc BAC transgenic mice exhibit no abnormality in glucose homeostasis and therefore could be useful as b-cell-specific reporter mice for study of pancreatic islets (Figure S2A ). To determine the relationship between the number of islets and the emission of bioluminescence, a variable number of equal-sized islets isolated from Ins1-luc BAC transgenic mice (n = 5) were placed individually in 24-well plates for 8 hours. The bioluminescence intensity emitted immediately after addition of luciferin to the Nafarelin site culture media correlated positively with the number of islets (R2 = 0.961) (Figure 3A). In addition, the bioluminescence emission from Ins1-luc BAC transgenic mice (8.1361.716105 photons/sec; n = 12) was about 4-fold higher than that from MIPLuc-VU mice (2.4160.826105 photons/sec; n = 7; P = 0.0087) (Figure 3B), consistent with the in vivo result shown in Figure 2D. Next, we examined whether BLI 23388095 of the mice could detect the loss of b-cell mass in an STZ-treated b-cell destruction model. On day 5 after the treatment, the luminescence in the pancreatic region of the STZ group (2.460.816105 photons/sec; n = 5) had dropped to undetectable background levels and was significantly reduced as compared with that of the control 
group (4.161.16106 photons/sec; n = 5; P = 0.025) in response to a decrease in b-cell mass (control: 0.7060.05 mg, n = 4; STZ: 0.01360.003 mg, n = 3; P = 0.0045) (Figure 4A ). We also examined whether BLI could sense the increase in bcell mass in HFD-fed mice. Ins1-luc BAC transgenic male mice fed either a RD (n = 4) or an HFD (n = 6) wer.Sisting of 62.2 fat, 19.6 carbohydrate, and 18.2 protein content on a caloric basis (Oriental Yeast, Tokyo, Japan). To assess the effect of the HFD on glucose homeostasis, the body fat composition and fasting blood glucose (FBG) levels of the mice were examined by means of a LaTheta computed tomography (CT) system (Hitachi Aloka Medical, Tokyo, Japan) and a Drichem 3500 (Fujifilm, Tokyo, Japan), respectively. Bioluminescence images were collected every 4 weeks beginning when the mice were 6 weeks of age.Preparation of recombinant adenovirus vectorsRecombinant adenoviruses expressing mouse Pdx1, NeuroD (kindly gifted by Dr S. Yoshida), and MafA were prepared 12926553 using a ViraPower Adenoviral Gateway Expression Kit (Invitrogen) [26]. In brief, cDNA fragments were cloned into a pENTR4 entryIns1-luc BAC Transgenic Micefrom the pancreas (Figure 2E). To examine the effect of overnight fasting on BLI, the BLI signals under the fasting and fed states of the same set of male Ins1-luc BAC transgenic mice (n = 5) were imaged at 3-day intervals. The intensity of the BLI signal under the fasting state (2.060.776106 photons/sec) did not differ from that under the fed state (1.7360.826106 photons/sec; P = 0.814) (Figure 2F). Furthermore, the intensity of the BLI signal emitted in females (2.5961.36106 photons/sec; n = 15) did not differ from that emitted in males (5.4161.36106 photons/sec; n = 19) at 8 weeks of age (P = 0.13). Although signal attenuation in RIP-Luc mice over generations was reported because of a genomic imprinting of the transgene [27], we did not find the phenomenon in Ins1-luc BAC transgenic mice over 3 generations (data not shown). Next, we compared the glucose homeostasis of control WT mice with that of Ins1-luc BAC transgenic mice. Every examination we tested, including blood glucose levels and insulin content in pancreatic islets, showed no difference between them, indicating that Ins1-luc BAC transgenic mice exhibit no abnormality in glucose homeostasis and therefore could be useful as b-cell-specific reporter mice for study of pancreatic islets (Figure S2A ). To determine the relationship between the number of islets and the emission of bioluminescence, a variable number of equal-sized islets isolated from Ins1-luc BAC transgenic mice (n = 5) were placed individually in 24-well plates for 8 hours. The bioluminescence intensity emitted immediately after addition of luciferin to the culture media correlated positively with the number of islets (R2 = 0.961) (Figure 3A). In addition, the bioluminescence emission from Ins1-luc BAC transgenic mice (8.1361.716105 photons/sec; n = 12) was about 4-fold higher than that from MIPLuc-VU mice (2.4160.826105 photons/sec; n = 7; P = 0.0087) (Figure 3B), consistent with the in vivo result shown in Figure 2D. Next, we examined whether BLI 23388095 of the mice could detect the loss of b-cell mass in an STZ-treated b-cell destruction model. On day 5 after the treatment, the luminescence in the pancreatic region of the STZ group (2.460.816105 photons/sec; n = 5) had dropped to undetectable background levels and was significantly reduced as compared with that of the control group (4.161.16106 photons/sec; n = 5; P = 0.025) in response to a decrease in b-cell mass (control: 0.7060.05 mg, n = 4; STZ: 0.01360.003 mg, n = 3; P = 0.0045) (Figure 4A ). We also examined whether BLI could sense the increase in bcell mass in HFD-fed mice. Ins1-luc BAC transgenic male mice fed either a RD (n = 4) or an HFD (n = 6) wer.
